See why people discuss them, what the evidence supports, and where amount information comes from.
Choose two compounds
Add up to four if you need to. Evidence labels apply to specific claims and products.
Compare more (up to four)
Tissue & skin
GLOW 70 mg Research Blend
A 70 mg blend listed as 50 mg GHK-Cu, 10 mg BPC-157, and 10 mg TB-4.
Why people are interested
GLOW is marketed as a skin-and-recovery blend because it combines GHK-Cu, BPC-157, and a thymosin-related ingredient.
What the research supports
Studies of individual ingredients cannot establish that the full 70 mg mixture works, or that its ingredients interact beneficially. The exact thymosin-related identity should be checked against the batch report.
Clinical or label amounts
Evidence gap
No amount established for this research vial
Publicly reported amounts
Amount in one post: about 1.67 mg GHK-Cu plus 0.33 mg each BPC-157 and thymosin component per stated 10 U
One checked post, not a typical amount or a recommendation.
Tirzepatide acts on GIP and GLP-1 receptors. It has been studied in human medicine products for blood sugar and metabolic effects.
Why people are interested
Tirzepatide is well known because prescription versions are used for type 2 diabetes, chronic weight management, and certain sleep-apnea patients. JD-2TR is a seller code associated with tirzepatide in listed batch reports.
What the research supports
The strongest evidence belongs to manufactured prescription tirzepatide products studied in clinical trials. FDA approval applies to those products and specific indications, not automatically to a research-only JD-2TR vial.
Clinical or label amounts
Prescription product label
2.5–15 mg
Once weekly in adults
Specific to the named study or medicine, not this research vial.
FDA-approved uses belong to named prescription products and indications; they do not transfer to an online research vial. Human, animal, cell, and anecdotal evidence are different. How we check sources →
Keep learning with PeptideWhy.Free, occasional article updates by email.Sign up +
The free email list
Good questions deserve clear answers.
Get occasional plain-English peptide guides and research updates from PeptideWhy. No account needed.